Terms: = Skin cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
22 results:
1. Pro-Inflammatory Cytokine Gene Expression in Penile cancer: Preliminary Studies.
Czajkowski M; Wierzbicki PM; Kotulak-Chrząszcz A; Małkiewicz B; Sosnowski R; Kmieć Z; Matuszewski M
Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763742
[No Abstract] [Full Text] [Related]
2. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract] [Full Text] [Related]
3. Patients presenting with metastases: stage IV uveal melanoma, an international study.
Garg G; Finger PT; Kivelä TT; Simpson ER; Gallie BL; Saakyan S; Amiryan AG; Valskiy V; Chin KJ; Semenova E; Seregard S; Filì M; Wilson M; Haik B; Caminal JM; Catala-Mora J; Gutiérrez C; Pelayes DE; Folgar AM; Jager MJ; Doğrusöz M; Luyten GPM; Singh AD; Suzuki S;
Br J Ophthalmol; 2022 Apr; 106(4):510-517. PubMed ID: 33452185
[TBL] [Abstract] [Full Text] [Related]
4. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
Ortega MA; Fraile-Martínez O; García-Honduvilla N; Coca S; Álvarez-Mon M; Buján J; Teus MA
Int J Oncol; 2020 Dec; 57(6):1262-1279. PubMed ID: 33173970
[TBL] [Abstract] [Full Text] [Related]
5. iris Melanoma Outcomes Based on the American Joint Committee on cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract] [Full Text] [Related]
6. [Diagnosis and Therapy of iris Lesions].
Mor JM; Koch KR; Heindl LM
Klin Monbl Augenheilkd; 2017 Dec; 234(12):1541-1554. PubMed ID: 29156467
[TBL] [Abstract] [Full Text] [Related]
7. Regression Patterns of iris Melanoma after Palladium-103 (
Chaugule SS; Finger PT
Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
[TBL] [Abstract] [Full Text] [Related]
8. Management and Outcome of Uveal Melanoma in a Single Tertiary cancer Center in Jordan.
Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA
Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393
[TBL] [Abstract] [Full Text] [Related]
9. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract] [Full Text] [Related]
10. Uveal melanoma: estimating prognosis.
Kaliki S; Shields CL; Shields JA
Indian J Ophthalmol; 2015 Feb; 63(2):93-102. PubMed ID: 25827538
[TBL] [Abstract] [Full Text] [Related]
11. International Validation of the American Joint Committee on cancer's 7th Edition Classification of Uveal Melanoma.
AJCC Ophthalmic Oncology Task Force
JAMA Ophthalmol; 2015 Apr; 133(4):376-83. PubMed ID: 25555246
[TBL] [Abstract] [Full Text] [Related]
12. Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
Corrie PG; Marshall A; Dunn JA; Middleton MR; Nathan PD; Gore M; Davidson N; Nicholson S; Kelly CG; Marples M; Danson SJ; Marshall E; Houston SJ; Board RE; Waterston AM; Nobes JP; Harries M; Kumar S; Young G; Lorigan P
Lancet Oncol; 2014 May; 15(6):620-30. PubMed ID: 24745696
[TBL] [Abstract] [Full Text] [Related]
13. Choroidal melanoma: clinical features, classification, and top 10 pseudomelanomas.
Shields CL; Manalac J; Das C; Ferguson K; Shields JA
Curr Opin Ophthalmol; 2014 May; 25(3):177-85. PubMed ID: 24614143
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification.
Brunner M; Ng BC; Veness MJ; Clark JR
Head Neck; 2015 Mar; 37(3):336-9. PubMed ID: 24415458
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer.
Brunner M; Ng BC; Veness MJ; Clark JR
Laryngoscope; 2014 Jul; 124(7):1598-602. PubMed ID: 24307576
[TBL] [Abstract] [Full Text] [Related]
16. Risk-reducing mastectomy.
Edlich RF; Winters KL; Faulkner BC; Lin KY
J Long Term Eff Med Implants; 2006; 16(4):301-14. PubMed ID: 17073572
[TBL] [Abstract] [Full Text] [Related]
17. Tumours of familial origin in the head and neck.
Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
[TBL] [Abstract] [Full Text] [Related]
18. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract] [Full Text] [Related]
19. Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).
Spatola C; Privitera G; Raffaele L; Salamone V; Cuttone G; Cirrone P; Sabini MG; Lo Nigro S
Tumori; 2003; 89(5):502-9. PubMed ID: 14870772
[TBL] [Abstract] [Full Text] [Related]
20. Brachytherapy in primary ocular tumors.
Freire JE; De Potter P; Brady LW; Longton WA
Semin Surg Oncol; 1997; 13(3):167-76. PubMed ID: 9143054
[TBL] [Abstract] [Full Text] [Related]
[Next]
